Drug intelligence / Profile preview

FID123238

Development stage: Preclinical
Administration: Ophthalmic

Overview

FID123238 is an investigational ophthalmic product evaluated for symptomatic relief in patients with moderate dry eye disease. The product was tested in multiple specification levels (minimum, moderate, moderate plus, maximum) applied as a single-dose intervention, and was compared with the commercially available Systane Hydration, a lubricating eye drop. Its precise composition, mechanism of action, and regulatory status have not been publicly disclosed. Efficacy and comfort outcomes were assessed in a randomized trial setting.

Beyond the preview

Go deeper on FID123238.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FID123238.

Explore the full profile